Xyz screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 21: | Line 21: | ||
OR | OR | ||
*According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | *According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with: | ||
**[ | **[Condition 1] | ||
**[ | **[Condition 2] | ||
**[ | **[Condition 3] | ||
==References== | ==References== |
Revision as of 20:11, 14 August 2017
Xyz Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Xyz screening On the Web |
American Roentgen Ray Society Images of Xyz screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
According to the [guideline name], screening for [disease name] is not recommended.
OR
According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with [condition 1], [condition 2], and [condition 3].
Screening
- There is insufficient evidence to recommend routine screening for [disease/malignancy].
OR
- According to the [guideline name], screening for [disease name] is not recommended.
OR
- According to the [guideline name], screening for [disease name] by [test 1] is recommended every [duration] among patients with:
- [Condition 1]
- [Condition 2]
- [Condition 3]